AtriCure (ATRC) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 -1.25%
EPS Growth %: +92.3%
Financial Fact:
Net loss: -6.78M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +92.3%
Financial Fact:
Net loss: -6.78M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.21), $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $52.9 million versus the consensus estimate of $51.56 million.
GUIDANCE:
AtriCure sees FY2019 revenue of $220-228 million, versus the consensus of $223.45 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Hermès can regain momentum despite China weakness, Jefferies says
- Sun Communities names Ileana McAlary as general counsel and EVP
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
